News
AstraZeneca has signed an AI-led research agreement with China's CSPC Pharmaceutical Group worth up to $5.3 billion, which ...
Dec 3 (Reuters) - Anglo-Swedish drugmaker AstraZeneca (AZN.L), opens new tab has signed a deal worth up to $247 million with U.S. artificial intelligence (AI) biologics firm Absci (ABSI.O), opens ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback